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CD4 T Follicular Helper Cells in HIV
CD4 T follicular helper cells are vital for induction of long-lived humoral immunity; this specialized function makes them highly desirable immunological targets for designing an effective HIV vaccine. Intriguingly, TFH cells could also hold clues to a functional cure for HIV; as reservoirs of latent HIV during antiretroviral therapy (ART), TFH cells facilitate HIV persistence. This special topic "CD4 TFH cells in HIV" synthesizes reviews from experts in the field to explore, discuss, and share recent discoveries on the intricate relationship between TFH cells and HIV. This special topic also seeks to offer perspectives on areas needing further inquiry in this rapidly evolving field.
Despite the success of ART, achieving a functional cure for HIV, i.e., sustained viral suppression after ART interruption, remains a challenge due to persistence of viral sanctuaries under ART. As a result, there is a critical need to understand the reservoir to devise effective strategies to purge the latent virus and eliminate life-long dependence on ART. In this special topic, experts in the HIV field synthesize and evaluate recent discoveries in humans and non-human primate model systems to understand the complex dynamics of TFH cells during HIV infection. Leong et al. delineate potential cell intrinsic and extrinsic factors driving viral replication within TFH cells during HIV infection. These include lack of cellular host restriction factors within TFH cells, exclusion of cytolytic CD8 T cells from B cell follicles within germinal centers (GCs), and trapped virus on GC follicular dendritic cells; a constellation of factors that create a perfect storm to promote unfettered viral replication within GC TFH cells. molecules on TFH cells leading to abnormal B cell differentiation and apoptosis. However, antibody responses are not compromised in all HIV-infected individuals. In some infected individuals, broadly neutralizing antibodies that have acquired extensive hypermutation and even deletion/insertion mutations appear several years after initial infection. Zaunders et al. contend that not all immune responses are impotent but that effective immune responses drive virus evolution resulting in Envelope divergence and diversification. The generation of neoantigens in the infected host could recruit naive CD4 T cells, which upon activation drive viral replication leading to eventual depletion of CD4 T cells.
In their review, Graff-Dubois et al. assert that TFH cell frequency varies widely according to (i) the stage of HIV/SIV infection, (ii) the severity of the disease, and (iii) the ability to develop broadly neutralizing antibodies highlighting that a blanket increase or decrease in TFH cells is not a unifying characteristic of all HIV/SIV infections. Given the intricate link between virus and lymph node cells, blocking HIV replication in lymphoid tissues might be a prerequisite for induction of effective TFH responses and anti-HIV antibodies and could have the benefit of dramatically decreasing seeding of the latent reservoir. While the lymph node has received a great deal of attention, other compartments are also emerging as critical parameters deserving of attention. There is also emerging interest in studying TFH cells in mucosal compartments-this understanding of the TFH cell response in distinct tissue compartments with differences in viral dynamics will undoubtedly shed further insights in the relationship of CD4 TFH cells and HIV. Thus, there remains a great deal to learn about TFH cells, and as with HIV, these cells are likely to attract the attention of immunologists and virologists alike.
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